35 matches for your search in the start-up spotlight
rss
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists ...
We're an interdisciplinary team of scientist-entrepreneurs with extensive experience in machine learning, drug discovery, and building and scaling impactful technology businesses.
AOMS Technologies Inc. offers a fully integrated optical sensing technology using fiber optics to empower industries with uninterrupted monitoring of multidimensional performance data. AOMS offering is an end-to-end hardware/software solution integrated with state-of-art Industrial Internet of ...
NetraMark combines proprietary QML/ML algorithms with cross-domain expertise to bring ML commercialization into reality, starting with the pharmaceutical space in drug development, resurrection, and disease definition.
Imagia is leveraging advances in AI to enable accesible personalized care. We are delivering on the promise of radiomics to predict patient outcomes & detect disease specific markers from imaging data.
BenchSci's vision is to bring novel medicine to patients 50% faster by 2025. To achieve this, we're exponentially increasing the speed and quality of life-saving research by empowering scientists with the world's most advanced biomedical artificial intelligence. Backed by F-Prime, Gradient ...
Remedium AI is a startup company capitalizing on recent breakthrough developments in Artificial Intelligence, creating technologies that can address significant inefficiencies currently plaguing the pharmaceutical industry. The company uses advanced computational tools to drastically reduce the ...
ProteinQure is a Toronto based biotech firm. We create computational R&D tools to perform drug design in silico. We leverage quantum computing, molecular simulations and reinforcement learning to engineer novel therapeutics.
At Phenomic AI we’re developing deep learning solutions to accelerate drug discovery. What sets us apart is our ambition to seamlessly integrate AI with experiments; Imagine biologists receiving real time deep learning driven analysis of compound screens, medicinal chemists linked to ...
Like a lighthouse providing early warning in the dark of night, changes in language can signal cognitive decline decades before symptoms of dementia become apparent. Currently, over 47.5 million individuals in the world have dementia, and that number is expected to triple by 2050. At WinterLight ...
